Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03480451 · ClinicalTrials.gov registry record · NA

Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis

A NA study, sponsored by Medical College of Wisconsin.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT03480451: Clinical Trial NA study, sponsored by Medical College of Wisconsin.

NCT03480451 is a NA study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03480451, a NA study, was terminated before completion, sponsored by Medical College of Wisconsin.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, with 90% of patients reporting dyspnea at the time of diagnosis and this is strongly correlated with quality of life and mortality. As IPF progress, breathlessness worsens, physical functional capacity declines, and health-related quality of life deteriorates. Pulmonary rehabilitation (PR) can improve well-being in patients with other chronic lung disease, but little is known regarding PR in IPF.

Primary Outcome

This project is being withdrawn. No revisions to Outcomes is available. Will use COPE questionnaire.

Interventions

  • OTHER Multi-Disciplinary Patient Centered Rehab and Education

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2017-09-12
Est. Completion 2019-02-01
Phase NA
Medical College of Wisconsin

447 total trials

Why NCT03480451 stopped before completion

NCT03480451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Multi-Disciplinary Patient Centered Rehab and Education is the first listed.

NCT03480451 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03480451 about?

NCT03480451 is a clinical study titled "Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis". Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, with 90% of patients reporting dyspnea at the time of diagnosis and this is strongly correlated with qu...

What is the current status of trial NCT03480451?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-09-12. Estimated completion is 2019-02-01.

What interventions are being tested in trial NCT03480451?

The interventions under investigation include: Multi-Disciplinary Patient Centered Rehab and Education (OTHER).

Who is sponsoring clinical trial NCT03480451?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03480451's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03480451, the US trial registry maintained by the National Library of Medicine. NCT03480451 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.